Tenax Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $17.1M | $10.0M |
| FY2017 | — | $8.9M | $1.6M |
| FY2018 | — | $11.8M | $12.4M |
| FY2019 | — | $3.8M | $4.9M |
| FY2020 | — | $4.6M | $6.3M |
| FY2021 | — | $4.2M | $5.6M |
| FY2022 | — | $1.5M | $2.1M |
| FY2023 | — | $8.1M | $9.8M |
| FY2024 | — | $92.0M | $94.9M |
| FY2025 | — | $97.1M | $97.6M |